Company Profile: Thermo Fisher Scientific Inc. (TMO)
TMO insider trades (13 months) →$698.34 +2.30% vs. previous close · Market cap $258.75B
Today's multi-factor rank: 260 of 461 · see the ranking
Market and Valuation
Price & Market
52-Week Range
Volume
Valuation Multiples
Diluted EPS for the last 12 months: the four quarters ended Sep 26, 2026, from the accounts filed with the SEC on Oct 30, 2026. The P/E is the price divided by that EPS.
Dividends
Valuation Context
P/E vs sector (indicative)
Loading historical OHLCV database...
Financial Statements TTM (Trailing 12 Months)
Income Statement
Margins
Per Share
Diluted EPS for the last 12 months: the four quarters ended Sep 26, 2026, from the accounts filed with the SEC on Oct 30, 2026. The P/E is the price divided by that EPS.
Balance Sheet & Liquidity
Cash Flows
Profitability
Historical Evolution (Last 4 Years)
Income Statement
Balance Sheet
Cash Flow
EPS and Earnings Per Share
Key EPS Metrics
Diluted EPS for the last 12 months: the four quarters ended Sep 26, 2026, from the accounts filed with the SEC on Oct 30, 2026. The P/E is the price divided by that EPS.
Growth and Margins
Per Share
Cash Flows (TTM)
EPS Surprise History - Last 4 Quarters
Actual vs. Analyst Estimates · Green = beat expectations · Red = missed
| Quarter | Period | Actual EPS | Estimated EPS | Difference | Surprise % | Currency |
|---|
Ownership Structure
Ownership Distribution
Shares & Short Interest
Governance Score (1=Best, 10=Worst)
Top Institutional Holders
Position Change: ▲ Increased · ▼ Reduced · = Unchanged
| Organization | Report Date | % Shares | No. Shares | Value (USD) | Change % |
|---|
Top Mutual Funds
Position Change: ▲ Increased ▼ Decreased = Unchanged
| Fund | Report Date | % Shares | No. Shares | Value (USD) | Change % |
|---|
Recent Insider Trades
| Executive / Insider | Title | Date | Action | Shares |
|---|
Options Chain
CALLS
| Strike | Last | Bid | Ask | Vol. | O.I. | IV |
|---|
PUTS
| Strike | Last | Bid | Ask | Vol. | O.I. | IV |
|---|
Thermo Fisher Scientific Inc. (TMO) SEC filings: 10-K, 10-Q and 8-K
Direct links to financial reports filed with the SEC.
| Type | Date | Official link |
|---|---|---|
| 8-K | 2026-10-30 | View filing ↗ |
| 8-K | 2026-10-21 | View filing ↗ |
| 10-Q | 2026-07-31 | View filing ↗ |
| 8-K | 2026-07-23 | View filing ↗ |
| 11-K | 2026-06-23 | View filing ↗ |
| SD | 2026-05-28 | View filing ↗ |
| 8-K | 2026-05-26 | View filing ↗ |
| DEFA14A | 2026-05-11 | View filing ↗ |
| 10-Q | 2026-05-01 | View filing ↗ |
| 8-K | 2026-04-23 | View filing ↗ |
Company and Executive Profile
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
General Information
Key Executives
| Name | Title | Age | Total pay |
|---|---|---|---|
| Mr. Marc N. Casper | Chairman & CEO | 57 | 6.24M |
| Mr. Gianluca Pettiti | President, COO & President of Products and Technologies | 46 | 2.42M |
| Mr. James R. Meyer | Senior VP & CFO | 46 | - |
| Mr. Joseph R. Holmes | VP & Chief Accounting Officer | 45 | - |
| Mr. Ryan J. Snyder | Senior VP & Chief Information Officer | - | - |
| Dr. Karen E. Nelson Ph.D. | Chief Scientific Officer | - | - |
| Mr. Rafael Tejada | Vice President of Investor Relations | - | - |
| Mr. Thomas Bailey Shropshire Jr. | Senior VP and General Counsel | - | - |
You have seen the engine room
A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.